Correlation between IL-3 receptor expression and growth potential of human CD34+ hematopoietic cells from different tissues

Stem Cells

Volumn 17, Issue 5, 1999, Pages 265-272

  Huang, Shiang ^a   Chen, Zhang ^b   Yu, Ji Feng ^b   Young, Dennis ^a   Bashey, Asad ^a   Ho, Anthony D ^c   Law, Ping ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BD Technologies   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

CD123; CD34+ cells; Committed progenitors; Erythroid progenitors; Hematopoietic cells; IL 3 receptor

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CD34 ANTIGEN; CYTOKINE; ERYTHROPOIETIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 3 RECEPTOR; INTERLEUKIN 6; SOMATOMEDIN;

ARTICLE; CELL GROWTH; CELL LINEAGE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LYMPHOID CELL; PROTEIN EXPRESSION; STEM CELL; TISSUE DISTRIBUTION;

EID: 0032722187     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.170265     Document Type: Article

References (62)

1. Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood 1993;81:2844-2853.
2. Moore MA. Review: Stratton Lecture 1990. Clinical implications of positive and negative hematopoietic stem cell regulators. Blood 1991;78:1-19.
3. Sieff C, Niemeyer C, Nathan D et al. Stimulation of human hematopoietic colony formation by recombinant gibbon multi-colony-stimulating factor or interleukin-3. J Clin Invest 1987;380:818-823.
4. Kimura T, Sakabe H, Tanimukai S et al. Simultaneous activation of signals through gp130, c-kit, and interleukin-3 receptor promotes a trilineage blood cell production in the absence of terminally acting lineage-specific factors. Blood 1997;90:4767-4778.
5. - cells in stroma-derived soluble factors, interleukin-3, and macrophage inflammatory protein-1 alpha maintains not only myeloid but also lymphoid progenitors in a novel switch culture assay. Blood 1998;91:4516-4522.
6. Kawada H, Ando K, Tsuji T et al. Rapid ex vivo expansion of human umbilical cord hematopoietic progenitors using a novel culture system. Exp Hematol 1999;27:904-915.
7. + early megakaryocytic marrow cells cultured on normal osteoblasts. STEM CELLS 1999;17:92-99.
8. + hematopoietic progenitors: role of granulocyte-macrophage colony-stimulating factor/erythropoietin hybrid protein (MEN11303) and interleukin-15. Exp Hematol 1999;27:416-424.
9. Lévêque C, Grafte S, Paysant J et al. Regulation of interleukin 3 receptor alpha chain (IL-3R alpha) on human monocytes by interleukin (IL)-4, IL-10, IL-13, and transforming growth factor beta (TGF-beta). Cytokine 1998;10:487-494.
10. McKinstry WJ, Li CL, Rasko JE et al. Cytokine receptor expression on hematopoietic stem and progenitor cells. Blood 1997;89:65-71.
11. Miyajima A, Hara T, Kitamura T. Common subunits of cytokine receptors and the functional redundancy of cytokines. Trends Biochem Sci 1992;17:378-382.
12. + cells: messenger RNA analysis. J Allergy Clin Immunol 1996;98:344-354.
13. Testa U, Fossati C, Samoggia P et al. Expression of growth factor receptors in unilineage differentiation culture of purified hematopoietic progenitors. Blood 1996;88:3391-3406.
14. Donahue R, Seehra J, Metzger M et al. Human IL-3 and GM-CSF act synergistically in stimulating hematopoiesis in primates. Science 1988;241:1820-1823.
15. van Gils F, van Teeffelen M, Neelis K et al. Interleukin-3 treament of Rhesus monkeys leads to increased production of histamine-releasing cells that express interleukin-3 receptors at high levels. Blood 1995;86:592-597.
16. Ganser A, Lindemann A, Seipelt G et al. Effect of recombinant human interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failure. Blood 1990;76:666-676.
17. Wagemaker G, van Gils F, Burger H et al. Highly increased production of derived blood cells by adminstration of homologous IL-3 to rhesus monkeys. Blood 1990;76:2235-2241.
18. Brugger W, Heimfeld S, Berenson RJ et al. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo [see comments]. N Engl J Med 1995;333:283-287.
19. Holyoake TL, Alcorn MJ, Richmond L et al. CD34 positive PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimens. Bone Marrow Transplant 1997;19:1095-1101.
20. Genechea G, Segovia JC, Albella B et al. Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells. Blood 1999;93:1097-1105.
21. Yonemura Y, Ku H, Hirayama F et al. Interleukin-3 or interleukin-1 abrogates the reconstituting ability of hematopoietic stem cells. Proc Natl Acad Sci USA 1996;93:4040-4044.
22. Matsunaga T, Hirayama F, Yonemura Y et al. Negative regulation by interleukin-3 (IL-3) of mouse early B-cell progenitors and stem cells in culture: transduction of the negative signals by betac and betaIL-3 proteins of IL-3 receptor and absence of negative regulation by granulocyte-macrophage colony-stimulating factor. Blood 1998;92:901-907.
23. Tisdale JF, Hanazono Y, Sellers SE et al. Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability. Blood 1998;92:1131-1141.
24. Park L, Friend D, Price V et al. Heterogeneity in human interleukin-3 receptors. A subclass that binds human granulocyte/macrophage colony stimulating factor. J Biol Chem 1989;264:5420-5427.
25. Gesner TG, Mufson RA, Norton CR et al. Specific binding, internalization, and degradation of human recombinant interleukin-3 by cells of the acute myelogenous, leukemia line, KG-1. J Cell Physiol 1988;136:493-499.
26. Uckun FM, Gesner TG, Song CW et al. Leukemic B-cell precursors express functional receptors for human interleukin-3. Blood 1989;73:533-542.
27. Budel LM, Elbaz O, Hoogerbrugge H et al. Common binding structure for granulocyte macrophage colony-stimulating factor and interleukin-3 on human acute myeloid leukemia cells and monocytes. Blood 1990;75:1439-1445.
28. Kitamura T, Sato N, Arai K et al. Expression cloning of the human IL-3 receptor cDNA reveals a shared beta subunit for the human IL-3 and GM-CSF receptors. Cell 1991;66:1165-1174.
29. Barry SC, Korpelainen E, Sun Q et al. Roles of the N and C terminal domains of the interleukin-3 receptor alpha chain in receptor function. Blood 1997;89:842-852.
30. Nicola NA, Metcalf D. Subunit promiscuity among hemopoietic growth factor receptors. Cell 1991;67:1-4.
31. Lopez A, Elliott M, Woodcock J et al. GM-CSF, IL-3 and IL-5: cross-competition on human hematopoietic cells. Immunol Today 1992;18:495-500.
32. Bagley CJ, Woodcock JM, Stomski FC et al. The structural and functional basis of cytokine receptor activation: lessons from the common beta subunit of the granulocyte-macrophage colony-stimulating factor, interleukin-3 (IL-3), and IL-5 receptors. Blood 1997;89:1471-1482.
33. McCormack MP, Gonda TJ. Expression of activated mutants of the human interleukin-3/interleukin-5/granulocyte-macrophage colony-stimulating factor receptor common beta subunit in primary hematopoietic cells induces factor-independent proliferation and differentiation. Blood 1997;90:1471-1481.
34. van Gils F, Budel L, Burger H et al. Interleukin-3 (IL-3) receptor on rhesus monkey cell: species specificity of human IL-3, binding characteristics, and lack of competition with GM-CSF. Exp Hematol 1994;22:248-255.
35. + hemopoietic cells. Leuk Lymphoma 1996;24:11-25.
36. Sato N, Caux C, Kitamura T et al. Expression and factor-dependent modulation of the interleukin-3 receptor subunits on human hematopoietic cells. Blood 1993;82:752-761.
37. Wagner J, Collins D, Fuller S et al. Isolation of small primitive human hematopoietic stem cells: distribution of cell surface cytokine receptors and growth in SCID-Hu mice. Blood 1995;86:512-523.
38. + human marrow cells that express low levels of Kit protein are enriched for long-term marrow-engrafting cells. Blood 1996;87:4136-4142.
39. low cells in which anti-TGF-beta upmodulates c-kit. Blood 1995;86:1729-1735.
40. + c-kitcells: correlation between long-term culture-initiating cells and telomerase expression. Leukemia 1998;12:728-734.
41. (low) phenotype identifies a marrow cell population highly enriched for human hematopoietic stem cells. Leukemia 1998;12:942-950.
42. Lane T, Law P, Maruyama M et al. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation. Blood 1995;85:272-282.
43. Lane TA, Ho AD, Bashey A et al. Mobilization of blood-derived stem and progenitor cells in normal subjects by granulocyte-macrophage- and granulocyte-colony-stimulating factors. Transfusion 1999;39:3947.
44. Huang S, Terstappen LW. Formation of haematopoietic microenvironment and haematopoietic stem cells from single human bone marrow stem cells [retraction of Huang S, Terstappen LW. In: Nature 1992;360:745-749]. Nature 1994;368:664.
45. - hematopoietic stem cells. Blood 1994;83:1515-1526.
46. Huang S, Law P, Young D et al. Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood versus adult bone marrow and mobilized peripheral blood. Exp Hematol 1998;26:1162-1171.
47. - progenitor cells. Blood 1991;77:1218-1227.
48. Terstappen L, Gandour D, Huang S et al. Assessment of hematopoietic cell differentiation by multidimensional flow cytometry. J Hematother 1993;2:431-447.
49. + human hematopoietic progenitors from fetal liver, cord blood, and adult bone marrow respond differently to hematopoietic cytokines depending on the ontogenic source. Exp Hematol 1998;26:1034-1042.
50. Zandstra PW, Conneally E, Piret JM et al. Ontogeny-associated changes in the cytokine responses of primitive human haemopoietic cells. Br J Haematol 1998;101:770-778.
51. Baum CM, Weissman IL, Tsukamoto AS et al. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA 1992;89:2804-2808.
52. - cells with both lymphoid and myeloid potential. Blood 1998;91:4145-4151.
53. + subsets in leukapheresis products mobilized by G-CSF, GM-CSF versus a combination of both. Exp Hematol 1996;24:1460-1468.
54. + hematopoietic progenitor cells: a five dimensional flow cytometric study. Haematologia 1998;83:587-592.
55. Dick JE. Absence of CD34 on some human SCID-repopulating cells. Ann NY Acad Sci 1999;872:211-217; discussion 217-219.
56. - hematopoietic stem cell populations. Exp Hematol 1999;27:788-796.
57. - stem cells as the earliest precursors of hematopoietic progeny [letter]. Exp Hematol 1998;26:1022-1023.
58. Nakauchi H. Hematopoietic stem cells: are they CD34-positive or CD34-negative? [news; comment]. Nat Med 1998;4:1009-1010.
59. Nakauchi H, Takano H, Ema H et al. Further characterization of CD34-low/negative mouse hematopoietic stem cells. Ann NY Acad Sci 1999;872:57-66; discussion 66-70.
60. Osawa M, Hanada K, Hamada H et al. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 1996;273:242-245.
61. + cells. Exp Hematol 1998;26:353-360.
62. - cells in vivo. Ann NY Acad Sci 1999;872:220-231; discussion 231-232.